The Moving Average Convergence Divergence (MACD) for ALGN turned positive on October 08, 2026. Looking at past instances where ALGN's MACD turned positive, the stock continued to rise in 31 of 42 cases over the following month. The odds of a continued upward trend are 74%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ALGN's RSI Indicator exited the oversold zone, 27 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on ALGN as a result. In 55 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
Following a +2.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGN advanced for three days, in 192 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
ALGN broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ALGN entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. ALGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.526) is normal, around the industry mean (4.940). P/E Ratio (26.082) is within average values for comparable stocks, (36.759). Projected Growth (PEG Ratio) (0.611) is also within normal values, averaging (4.456). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.612) is also within normal values, averaging (56.074).
The Tickeron SMR rating for this company is 69 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The RSI Oscillator for LFWD moved into overbought territory on October 20, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
LFWD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LFWD as a result. In 79 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The 50-day moving average for LFWD moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFWD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for LFWD entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 46 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.275) is normal, around the industry mean (2.979). P/E Ratio (-0.375) is within average values for comparable stocks, (2.590). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.574) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. LFWD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFWD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
ALGN | LFWD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 22 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 63 Fair valued | 46 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 69 | 100 | |
PRICE GROWTH RATING 1..100 | 59 | 76 | |
P/E GROWTH RATING 1..100 | 25 | 17 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
LFWD's Valuation (46) in the Medical Specialties industry is in the same range as ALGN (63). This means that LFWD’s stock grew similarly to ALGN’s over the last 12 months.
LFWD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ALGN (100). This means that LFWD’s stock grew similarly to ALGN’s over the last 12 months.
ALGN's SMR Rating (69) in the Medical Specialties industry is in the same range as LFWD (100). This means that ALGN’s stock grew similarly to LFWD’s over the last 12 months.
ALGN's Price Growth Rating (59) in the Medical Specialties industry is in the same range as LFWD (76). This means that ALGN’s stock grew similarly to LFWD’s over the last 12 months.
LFWD's P/E Growth Rating (17) in the Medical Specialties industry is in the same range as ALGN (25). This means that LFWD’s stock grew similarly to ALGN’s over the last 12 months.
| ALGN | LFWD | |
|---|---|---|
| RSI ODDS (%) | 6 days ago 71% | 2 days ago 89% |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 76% |
| Momentum ODDS (%) | 2 days ago 69% | 2 days ago 90% |
| MACD ODDS (%) | 2 days ago 74% | N/A |
| TrendWeek ODDS (%) | 2 days ago 73% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 72% | 2 days ago 89% |
| Advances ODDS (%) | 2 days ago 70% | N/A |
| Declines ODDS (%) | 17 days ago 75% | 6 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 74% | 2 days ago 82% |
| Aroon ODDS (%) | 2 days ago 76% | 2 days ago 89% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALGN’s FA Score shows that 1 FA rating(s) are green while LFWD’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALGN’s TA Score shows that 4 TA indicator(s) are bullish while LFWD’s TA Score has 3 bullish TA indicator(s).
ALGN (@Pharmaceuticals: Other) experienced а +4.85% price change this week, while LFWD (@Medical/Nursing Services) price change was -9.84% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.88%. For the same industry, the average monthly price growth was -2.82%, and the average quarterly price growth was +8.10%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.18%. For the same industry, the average monthly price growth was -9.32%, and the average quarterly price growth was -10.26%.
ALGN is expected to report earnings on Oct 28, 2026.
LFWD is expected to report earnings on Nov 13, 2026.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-0.18% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor tells us that LFWD and MBOT have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFWD and MBOT's prices will move in lockstep.
| Ticker / NAME | Correlation To LFWD | 1D Price Change % | ||
|---|---|---|---|---|
| LFWD | 100% | -10.86% | ||
| MBOT - LFWD | 27% Poorly correlated | -0.56% | ||
| ALGN - LFWD | 27% Poorly correlated | +1.00% | ||
| UFPT - LFWD | 25% Poorly correlated | -0.65% | ||
| LUCD - LFWD | 25% Poorly correlated | -6.76% | ||
| QSI - LFWD | 25% Poorly correlated | +6.42% | ||
More | ||||